SUBSCRIBE
SUBSCRIBE
News   Deals

Agilent Technologies Inc. Acquires BIOCIUS Life Sciences, Inc., Lab901

March 1, 2011 | 
1 min read
GenomeWeb -- NEW YORK (GenomeWeb News) — Agilent Technologies separately announced today and yesterday that has acquired Biocius Life Sciences and Lab901. Financial and other terms of the deals were not disclosed.
Mergers & acquisitions
Agilent Technologies
MORE ON THIS TOPIC
Gentilly, France, March 21, 2021: Exterior view of the Sanofi headquarters building. Sanofi is a French multinational company specializing in the health sector
Autoimmune disease
Sanofi Joins With EVOQ in $500M Autoimmune Alliance
October 16, 2025
 · 
2 min read
 · 
Tristan Manalac
Facade of Novo Nordisk's office in Fremont, California
Rare diseases
Novo Offers up to $2.1B for Omeros’ Complement Drug To Expand Rare Disease Work
October 15, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Pictured: Bristol Myers Squibb office in California
ALS
BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line
October 15, 2025
 · 
1 min read
 · 
Tristan Manalac
Creative poster collage of two business partners having deal financial payment giving money banknote isolated on beige color background.
Mergers & acquisitions
BioCryst Snaps Up Fellow Angiodema Player Astria for $700M
October 15, 2025
 · 
2 min read
 · 
Tristan Manalac